Jeffrey Burris left the role of Chief Legal Officer at Indivior Pharmaceuticals on November 2, 2026, according to an SEC filing.
| Name | Jeffrey Burris |
|---|---|
| Role | Chief Legal Officer |
| Company | Indivior Pharmaceuticals |
| Industry | Pharmaceuticals |
| Location | North Chesterfield, VA |
| Move | Departure |
| Date | November 2, 2026 |
| Source | an SEC filing |
Indivior Pharmaceuticals reported that Jeffrey Burris ceased to serve as its Chief Legal Officer on November 2, 2026, when its business combination with Supernus Pharmaceuticals closed. He was one of four Indivior executives who left at closing, and he entered into a separation agreement with the company the same day. Supernus CEO Jack A. Khattar became chief executive of the combined company. (Source: an SEC filing.)
Other general counsel moves in November 2026
- Katie Rowen Named Executive Vice President and Chief Legal Officer of Johnson Controls (November 2, 2026)
- Lee Giguere Named Chief Legal Officer of Caldera Therapeutics (November 2, 2026)
- John S. Jenkins, Jr. Steps Down as Executive Vice President and General Counsel of TE Connectivity (November 2, 2026)
- Jennifer A. Johnson Named Executive Vice President and Chief Legal Officer of TE Connectivity (November 2, 2026)
- Michael Schade Named Vice President and General Counsel of Long Island University (November 2, 2026)
Planning your own next move?
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.
Does this information need updating? Email us at info@inhouseblog.com.